AcSIR PhD Programme January 2022 Announced - Applications Invited

CSIR-IHBT PhD Programme January 2022 Announced

Invites Applications for Ph.D. Programme of Academy of Scientific and Innovative Research (AcSIR) January 2022 Session. CSIR-IHBT, a premier research institute of the Council of Scientific and Industrial Research (CSIR), invites applications for Ph.D. Programme under Academy of Scientific and Innovative Research (AcSIR) from eligible candidates.

Eligibility Criteria:

Ph.D. (Science): Master’s Degree in Science and a valid National Level Fellowship NET-JRF/SRF of various funding agencies (CSIR/UGC/RGNF/DBT/ICMR/BINC/INSPIRE or other equivalent fellowships) for the Ph.D. program at CSIR-IHBT:

(i) Master’s degree in  Pharmaceutical Sciences (Pharmacology & Pharmacology and Toxicology)

(ii) Chemical Sciences- Master’s degree in Organic Chemistry/ Analytical Chemistry/ Inorganic Chemistry/ Physical Chemistry/ Chemistry/ Pharmaceutical Chemistry. Candidates with GATE/ G-PAT fellowship are not eligible.

Existing Research Fellows/ Projects Assistants working at CSIR- IHBT for a minimum period of 1 year are eligible to apply.

CSIR Group III/ IV staff who fulfill the academic qualifications are also eligible to apply for Ph.D. in Part-Time mode with the approval of the Lab Director.

Admission criteria for SC/ST/OBC/Women/ Physically Handicapped/ EWS candidates are relaxable as per GoI rules.

How to Apply:

For details about application and admission procedures, candidates are requested to visit the website http://acsir.res.in. Interested candidates who fulfill the eligibility criteria can apply online at http://acsir.res.in before October 31, 2021.

To know more about AcSIR and CSIR-IHBT please visit http://acsir.res.in and http://ihbt.res.in/

View Main Notification

Editors Note: CSIR-IHBT PhD Programme Subscribe to Rasayanika for the latest chemistry and Pharma job openings, follow us on Facebook and Telegram and subscribe to our youtube channel for the latest updates on chemistry and Pharma jobs and much more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here